Aberrantly regulated dysadherin and B-cell lymphoma 2/B-cell lymphoma 2-associated X enhances tumorigenesis and DNA targeting drug resistance of liver cancer stem cells

Cancer stem cells (CSCs) in hepatocellular carcinoma (HCC) are frequently resistant to current therapeutic regimens and therefore responsible for tumor recurrence. Previous studies have reported that expression levels of dysadherin in CSCs may be used as a prognostic indicator, which is also respons...

Descripción completa

Detalles Bibliográficos
Autores principales: JIANG, NAN, CHEN, WEI, ZHANG, JIAN-WEN, LI, YANG, ZENG, XIAN-CHENG, ZHANG, TONG, FU, BIN-SHENG, YI, HUI-MIN, ZHANG, QI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626168/
https://www.ncbi.nlm.nih.gov/pubmed/26458963
http://dx.doi.org/10.3892/mmr.2015.4363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626168/
https://www.ncbi.nlm.nih.gov/pubmed/26458963
http://dx.doi.org/10.3892/mmr.2015.4363

Ejemplares similares